Comparative clinical study· 2008
Efficacy and possible mechanisms of action of a new peptide anxiolytic Selank in the therapy of generalized anxiety disorders and neurasthenia
Zozulia AA|et al.
Zhurnal Nevrologii i Psikhiatrii imeni S.S. Korsakova
- PubMed
- 18454096
- Evidence level
- low
- Verification
- verified
Summary
Comparative study of Selank and medazepam in 62 patients.
Limitations
Small study|Comparator rather than placebo|Regional publication|Limited blinding information